Clinical Trials on Undefined T Cell Deficiency Disorder in United States
Total 8091 results
-
Baylor College of MedicineCenter for Cell and Gene Therapy, Baylor College of MedicineTerminatedSevere Combined Immunodeficiency Disease | Severe Primary Immunodeficiency Disorder | Undefined T Cell Deficiency Disorder | Wiskott-Aldrick SyndromeUnited States
-
National Cancer Institute (NCI)CompletedPeripheral T-Cell Lymphoma (PTCL) | T-Cell Prolymphocytic Leukemia | Cutaneous T Cell Lymphoma (CTCL) | T-Cell Lymphoma Relapsed | Adult T-Cell Leukemia (ATL)United States
-
University of Alabama at BirminghamTerminatedAnaplastic Large Cell Lymphoma | Angioimmunoblastic T-cell Lymphoma | Peripheral T-cell Lymphomas | Adult T-cell Leukemia | Adult T-cell Lymphoma | Peripheral T-cell Lymphoma Unspecified | T/Null Cell Systemic Type | Cutaneous t-Cell Lymphoma With Nodal/Visceral DiseaseUnited States
-
National Cancer Institute (NCI)WithdrawnHepatosplenic T-cell Lymphoma | Enteropathy-Associated T-Cell Lymphoma | Adult T-cell Leukemia/Lymphoma | Extranodal NK-/T-cell Lymphoma, Nasal Type | Monomorphic Epiteliotrophic Intestinal T-cell LymphomaUnited States
-
National Cancer Institute (NCI)CompletedAcute Adult T-Cell Leukemia/Lymphoma | Adult T-Cell Leukemia/Lymphoma | Chronic Adult T-Cell Leukemia/Lymphoma | HTLV-1 Infection | Lymphomatous Adult T-Cell Leukemia/Lymphoma | Smoldering Adult T-Cell Leukemia/LymphomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingCutaneous T-Cell Lymphoma | Peripheral T-Cell Lymphoma | Mature T-cell Malignancies | Relapsed/ Refractory T-cell MalignanciesUnited States
-
Ohio State University Comprehensive Cancer CenterCelgene CorporationRecruitingCutaneous T-cell Lymphoma | Peripheral T-Cell Lymphoma | T-Prolymphocytic Leukemia | T-Large Granulocytic Leukemia | T-Lymphoblastic Leukemia/LymphomaUnited States
-
Dana-Farber Cancer InstituteRecruitingCutaneous T Cell Lymphoma | Peripheral T Cell LymphomaUnited States
-
University of WashingtonNational Cancer Institute (NCI)TerminatedCutaneous T-cell Lymphoma Stage I | Cutaneous T-cell Lymphoma Stage II | Cutaneous T-cell Lymphoma Stage III | Cutaneous T-cell Lymphoma Stage IVUnited States
-
Washington University School of MedicineWugen, Inc.RecruitingAcute Myeloid Leukemia | Sezary Syndrome | Anaplastic Large Cell Lymphoma | Angioimmunoblastic T-cell Lymphoma | Adult T Cell Leukemia | Adult T Cell Lymphoma | Hepatosplenic T-cell Lymphoma | Peripheral T Cell Lymphoma | Extranodal NK/T-cell Lymphoma | Enteropathy-Associated T-Cell Lymphoma | T-Cell Non-Hodgkin... and other conditionsUnited States
-
National Cancer Institute (NCI)CompletedLymphoma | Cutaneous | T-CellUnited States
-
National Cancer Institute (NCI)CompletedLymphoma, T-Cell, Cutaneous | Leukemia, T-CellUnited States
-
Northwestern UniversityRecruitingCutaneous T Cell LymphomaUnited States
-
Fox Chase Cancer CenterCelgene Corporation; Seagen Inc.Active, not recruitingCutaneous T-cell Lymphoma (CTCL)United States
-
Abramson Cancer Center of the University of PennsylvaniaCompletedCutaneous T Cell LymphomaUnited States
-
Northwestern UniversityNot yet recruitingCutaneous T Cell LymphomaUnited States
-
NYU Langone HealthLudwig Institute for Cancer ResearchTerminatedCutaneous T-cell LymphomaUnited States
-
University of Medicine and Dentistry of New JerseyOrtho Biotech, Inc.Terminated
-
Pierluigi PorcuMillennium Pharmaceuticals, Inc.; Celgene CorporationCompletedPeripheral T-cell Lymphoma | Anaplastic Large Cell Lymphoma | Angioimmunoblastic T-cell Lymphoma | Adult Nasal Type Extranodal NK/T-cell Lymphoma | Hepatosplenic T-cell Lymphoma | Post-transplant Lymphoproliferative Disorder | Recurrent Adult T-cell Leukemia/Lymphoma | Recurrent Cutaneous T-cell... and other conditionsUnited States
-
Kyowa Kirin Co., Ltd.Kyowa Hakko Kirin Pharma, Inc.CompletedCutaneous T-cell Lymphoma | Peripheral T-cell LymphomaUnited States
-
M.D. Anderson Cancer CenterCompletedLymphoma | Disorder Related to Bone Marrow TransplantationUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingCutaneous T-cell LymphomaUnited States
-
EQRx International, Inc.No longer availableExtranodal NK/T-cell LymphomaUnited States
-
Columbia UniversityCelgene CorporationCompleted
-
Dana-Farber Cancer InstituteLeadiant Biosciences, Inc.TerminatedT-Cell Lymphoma | Relapsed T-Cell Lymphoma | Refractory T-Cell LymphomaUnited States
-
National Cancer Institute (NCI)RecruitingAcute Adult T-Cell Leukemia/Lymphoma | Adult T-Cell Leukemia/Lymphoma | Chronic Adult T-Cell Leukemia/Lymphoma | HTLV-1 InfectionUnited States
-
National Cancer Institute (NCI)TerminatedLeukemia, Adult T-Cell | T Cell Leukemia, Adult | T Cell Leukemia, HTLV I AssociatedUnited States
-
Deepa JagadeeshRecruitingAngioimmunoblastic T-cell Lymphoma | T-cell Lymphoma | Adult T-cell Leukemia/Lymphoma | Enteropathy Associated T-cell Lymphoma | Hepato-splenic T-cell Lymphoma | NK T-cell LymphomaUnited States
-
University of NebraskaNational Cancer Institute (NCI); AmgenCompletedPeripheral T-cell Lymphoma | Anaplastic Large Cell Lymphoma | Angioimmunoblastic T-cell Lymphoma | Adult Nasal Type Extranodal NK/T-cell Lymphoma | Recurrent Adult T-cell Leukemia/LymphomaUnited States
-
Legend Biotech USA IncActive, not recruitingT-Cell Lymphoma | Peripheral T-Cell Lymphoma Refractory | Cutaneous T-Cell Lymphoma Refractory | Cutaneous T-Cell Lymphoma Recurrent | Peripheral T-Cell Lymphoma RecurrentUnited States
-
Falo, Louis, MDActive, not recruitingCutaneous T Cell LymphomaUnited States
-
Stefan Schieke MDWithdrawnCutaneous T-cell Lymphoma (CTCL)United States
-
Florida Academic Dermatology CentersCelgene CorporationUnknownCutaneous T Cell LymphomaUnited States
-
Weiyun AiCelgene CorporationCompletedLymphoma | T-Cell Lymphoma | Cutaneous LymphomaUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Immunoblastic Large Cell Lymphoma | Peripheral T-cell Lymphoma | Anaplastic Large Cell Lymphoma | Angioimmunoblastic T-cell Lymphoma | Hepatosplenic T-cell Lymphoma | Recurrent Adult T-cell Leukemia/Lymphoma | Recurrent Cutaneous T-cell...United States
-
Rhizen Pharmaceuticals SAWithdrawnPeripheral T Cell LymphomaUnited States
-
Adam LernerNovartisTerminated
-
M.D. Anderson Cancer CenterGalderma R&DCompleted
-
National Cancer Institute (NCI)RecruitingChronic Lymphocytic Leukemia (CLL) | Hairy Cell Leukemia (HCL) | Cutaneous T Cell Lymphoma (CTCL) | Non-Hodgkins Lymphoma (NHL) | Adult T Cell Lymphoma (ATL)United States
-
Cyclacel Pharmaceuticals, Inc.TerminatedA Randomized Phase II Study of Oral Sapacitabine in Patients With Advanced Cutaneous T-cell LymphomaCutaneous T-cell Lymphoma (CTCL)United States
-
National Cancer Institute (NCI)CompletedAdult T-Cell Leukemia (ATL)United States
-
Conjupro Biotherapeutics, Inc.CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Withdrawn
-
National Cancer Institute (NCI)TerminatedLeukemia, Adult T-CellUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteSeagen Inc.TerminatedPilot Study of Brentuximab Vedotin in Relapsed/Refractory Peripheral T-Cell Lymphoma Expressing CD30Peripheral T-Cell LymphomaUnited States
-
National Cancer Institute (NCI)Completed
-
Amit VermaTerminatedAdult T Cell Leukemia | Adult T Cell LymphomaUnited States
-
University of Michigan Rogel Cancer CenterWithdrawnCutaneous T Cell LymphomaUnited States
-
John ReneauRecruitingRecurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | Recurrent Adult T-Cell Leukemia/Lymphoma | Refractory Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | Refractory Adult T-Cell Leukemia/LymphomaUnited States
-
M.D. Anderson Cancer CenterCompletedChronic Lymphocytic Leukemia | Cutaneous T-cell Lymphoma | Peripheral T-cell LymphomaUnited States
-
University of California, San FranciscoWashington University School of Medicine; Eisai Inc.TerminatedPeripheral T-Cell LymphomaUnited States